Tanja Laschober PhD

Dr. Laschober is a Research Scientist at the Addictions, Drug & Alcohol Institute where she carries out multiple roles:

• National Project Director of CTN Protocol 0082 Implementation Survey of PrEP and Opioid Use Related Services in STI Clinics and MSM-Centered Community Based Organizations (CBOs) for the Pacific Northwest Node of The National Drug Abuse Treatment Clinical Trials Network (CTN)
• Project Manager for a UW/Fred Hutch CFAR grant-funded project that focuses on the expansion of harm reduction services at a syringe service program in Memphis, TN
• Consultant with the Clinical Trials Consultation and Technical Assistance Program (C-TAP) within the UW Department of Psychiatry and Behavioral Sciences
• Reviewer for the CTN Publications Committee

Dr. Laschober’s research experience spans across multiple decades and includes project management, data management, quantitative analysis, and writing to dissemination of findings. Her previous research has focused on the adoption, implementation, and sustainability of evidence-based practices; assessment of mandatory smoking cessation policies; and workforce development in substance use disorder treatment programs; evaluation of quality of care and outcomes in Medicaid and CHIP recipients; interventions to safely disclose HIV-positive status to family members and sexual partners; well-being across the lifespan; interpersonal and family relationships.